astellas pharma inc
(4503:Tokyo Stock Exchange)
Sef P. Kurstjens M.D., Ph.D.
Chief Medical Officer and President of Global Development, Astellas Pharma, Inc.
|Age||Total Calculated Compensation||This person is connected to 45 board members in 1 different organizations across 4 different industries.|
See Board Relationships
Dr. Sef P. Kurstjens, M.D., Ph.D. serves as Chief Medical Officer at Astellas Pharma US, Inc. Dr. Kurstjens has been the President of Astellas Pharma Global Development, Inc. since October 2013. Dr. Kurstjens serves as Chief Medical Officer of Astellas Pharma, Inc. Dr. Kurstjens has been the President and the Chief Executive Officer at Agensys, Inc. since November 2010. Dr. Kurstjens served as the Senior Vice President, Chief Medical Officer and Head, Global Drug Development ...
2-5-1, Nihonbashi-HonchoPhone: 81 3 3244 3000
Tokyo, -- 103-8411
Board Members Memberships*
Wits Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Vincent A. Forlenza BD||Chairman, Chief Executive Officer and President|
Becton, Dickinson and Company
|Heather Bresch||Chief Executive Officer, Director and Member of Science & Technology Committee|
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|Christophe Weber||President, Chief Operating Officer and Representative Director|
Takeda Pharmaceutical Company Limited
|Paul R. Perreault BA Psychology||Chief Executive Officer, Managing Director, Executive Director and Member of Innovation & Development Committee|
|$3.1M||Compensation as of Fiscal Year 2014.|